Clinical trial registry record

The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People

A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered early phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 25, 2016.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT01303484
Last registry update
March 25, 2016
Status
Completed
Phase
EARLY Phase 1
Sponsor
Clasado
Enrollment
40
Countries
United Kingdom
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
EARLY Phase 1
Study design
RANDOMIZED · CROSSOVER · TREATMENT · TRIPLE
Evidence population
Human clinical study registration
Participants
40
Population
ALL · 65 Years to 80 Years
Duration
2011-05-01 to 2014-07-01
Intervention
Bi2muno® GOS; Maltodextrin
Comparator
MDn; B-GOS
Outcomes measured
Effect of B-GOS on immunity by measuring various inflammatory/immune biomarkers — 12 months; Effect of B-GOS on the faecal microbiota composition of elderly persons — 12 months; Effect of aging on body metabolites using NMR — 12 months; Effect of B-GOS on gut permeability — 12 months; Weekly assessment of stools and gastrointestinal symptoms — 8 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · EARLY Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Microbiome and dysbiosis · 100%Title contains controlled term: gut microbiota. Abstract contains controlled term: gut microbiota. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

microbiome dysbiosis
Open primary sourceExport JSON